was concentrated. Generally, a bright yellow solid appeared,
which was filtered and washed with 1:1 mixture (20 mL) of
diethyl ether and petroleum ether. Otherwise, the residue was
diluted with ethyl acetate (50 mL), and the layers were sepa-
rated. The aqueous layer was extracted with ethyl acetate (3 ×
25 mL). The combined extracts were washed with brine and H2O,
dried (Na2SO4), and concentrated. The crude product was
purified by column chromatography on silica gel or by recrys-
tallization. This procedure was adopted for the preparation of
compounds 11 and 22.
2-(1,4-Dioxo-1,4-dihydronaphthalen-2-yl)benzoic Acid
(11): Yellow solid. mp 193-195 °C; 1H NMR (500 MHz, CDCl3)
δ 8.12 (d, J ) 7.4 Hz, 2H), 8.08 (dd, J ) 7.4 Hz, 1.3 Hz, 1H),
7.89-7.71 (m, 2H), 7.67 (dt, J ) 7.5 Hz, 1.2 Hz, 1H), 7.56 (dt, J
) 7.5 Hz, 1.2 Hz, 1H), 7.36 (d, J ) 7.5 Hz, 1H), 6.91 (s, 1H); 13
C
NMR (125 MHz, CDCl3) δ 185.3, 184.1, 169.6, 151.8, 136.1, 134.1,
134.0, 133.7, 133.7, 132.6, 132.5, 131.2, 130.5, 129.9, 129.3, 127.2,
126.3. MS EI (70 eV), m/z: 293 (100%), 278 (M+), 262, 248, 233,
222, 206, 176, 162. Anal. Calcd for C17H10O4: C, 73.38; H, 3.62.
Found: C, 73.31; H, 3.37.
FIGURE 2. ORTEP plot of X-ray crystal structure of 22.
an isomer of gilvocarcin M, was obtained in 94% yield.
Comparison of the NMR data with those of the litera-
ture15 authenticated the structure of the product. The
synthesis of 23 could be regarded as the formal total
synthesis of WS-5995 A and C (4b) antibiotics, which
have been previously synthesized10 from the methyl ether
derivative 24.
In summary, condensation of an appropriately substi-
tuted styryl sulfone with a phthalide has provided a
regiospecific convergent synthesis of benzo[d]naphtho-
[1,2-b]pyran-6-one nucleus of gilvocarcin antibiotics. This
route has resulted in a brief and efficient synthesis of
benzonaphthopyranone 23, an established late-stage
intermediate to WS-5995 A and C antibiotics. We believe
that this work should be applicable to other polycyclic
aromatic natural products, namely phenanthroviridins,
jadomycin A, kinamycins, and C-glycosidic polyketides.16
2-Methoxy-4-methylpivalanilide (18). Trimethylacetyl chlo-
ride (2.50 g, 20.75 mmol) was added dropwise to a stirred
mixture of 2-amino-5-methylphenol (2.00 g, 16.26 mmol) and
aqueous NaHCO3 (1.65 g, 19.64 mmol, in 10 mL of H2O) in
dichloromethane (20 mL) at room temperature. Stirring was
continued for 25 min, and then the resulting reaction mixture
was diluted with water (50 mL) and extracted with dichlo-
romethane (3 × 25 mL). The combined organic extracts were
washed with brine, dried (Na2SO4), and concentrated to provide
2-hydroxy-4-methylpivalanilide. Methyl iodide (2.27 mL, 5.15 g,
36.27 mmol) was added to a solution of 2-hydroxy-4-methylpiv-
alanilide and K2CO3 (7.0 g, 50 mmol) in dry acetone (25 mL) at
0 °C, and stirring was continued for 3 h. After completion of the
reaction, inorganic salts were filtered and the filtrate was
concentrated. The residue was diluted with ether (100 mL) and
successively washed with water (2 × 20 mL) and brine (20 mL),
dried over Na2SO4, and concentrated to give an oil. The crude
liquid was further purified by column chromatography on silica
gel (10% ethyl acetate-petroleum ether) to provide 2-methoxy-
4-methylpivalanilide (18) (3.38 g, 94%). 1H NMR (200 MHz,
CDCl3) δ 8.25 (d, J ) 8.1 Hz, 1H), 8.06-8.00 (brs, 1H), 6.75 (d,
J ) 8.1 Hz, 1H), 6.68 (s, 1H), 3.87 (s, 3H), 2.31 (s, 3H), 1.31 (s,
9H); 13C NMR (50 MHz, CDCl3) δ 176.2, 147.8, 133.1, 125.2,
121.3, 119.3, 110.6, 55.7, 39.8, 27.6, 21.3.
Methyl 3-Methoxy-5-methylanthranilate (19). n-Butyl-
lithium (1.6 M in hexane, 6.2 mL, 9.92 mmol) was added over a
period of 5 min to a stirred solution of 2-methoxy-4-methylpiv-
alanilide (1 g, 4.52 mmol) in THF (12 mL) at room temperature
under dry N2 atmosphere. After an additional 30 min, the
solution was cooled to -78 °C (ethyl acetate/liquid N2 bath),
carbonated by passing dry CO2 through the reaction mixture,
and stirred continually for 2 h while maintaining an internal
temperature of -78 °C. The reaction mixture was warmed to
room temperature and was quenched with saturated NaHCO3
solution (40 mL). The mixture was extracted with ethyl acetate
(2 × 20 mL). The resulting aqueous layer was acidified with
dilute HCl. The aqueous solution was successively extracted with
ethyl acetate (3 × 40 mL), dried (Na2SO4), and concentrated.
Purification of the crude product by recrystallization from ethyl
acetate-petroleum ether gave a white crystalline solid. The
white solid compound was refluxed with 10 mL of 25% aqueous
HCl in methanol (5 mL) for 12 h. After cooling, the reaction
mixture was diluted with H2O (30 mL) and extracted with ethyl
acetate (3 × 25 mL), washed with brine, dried (Na2SO4), and
concentrated to afford a solid residue. The residue was dissolved
in dry methanol (12 mL), and SOCl2 (0.9 mL, 12 mmol) was
added dropwise at 0 °C for 10 min. After being stirred for 1 h at
0 °C, the resulting reaction mixture was heated at reflux for 2
h. MeOH was removed, and the residue was diluted with
aqueous NaHCO3 solution (45 mL). The resulting mixture was
extracted with ether (3 × 25 mL). The combined organic phases
were washed with water and brine and concentrated. The
residue on column chromatographic purification afforded 19 as
an oil in 62% yield (550 mg). 1H NMR (200 MHz, CDCl3) δ 7.27
Experimental Section
General Procedure for Annulation. To a stirred solution
of lithium tert-butoxide (9.84 mmol) in THF (40 mL) at -60 °C
(chloroform/liquid N2 bath) under an inert atmosphere was
added a solution of a phthalide (3.28 mmol) in THF (5 mL). The
resulting yellowish solution was stirred at -60 °C for 25 min,
after which a solution of a Michael acceptor (1.0-1.5 equiv
unless otherwise stated) in THF (5 mL) was added to it. The
cooling bath was removed after about 1 h at -60 °C, and the
reaction mixture was brought to room temperature over a period
of 1 h and further stirred for 2-6 h. The reaction was then
quenched with 10% NH4Cl (15 mL), and the resulting solution
(12) (a) Hassner, A.; Stumer, C. Organic Syntheses Based on Name
Reactions; Pergamon: Amsterdam, 2002; p 153. (b) Mitchell, A. S.;
Russell, R. A. Tetrahedron 1995, 51, 5207-5236. (c) Hauser, F. M.;
Rhee, R. P. J. Org. Chem. 1978, 43, 178-180. (d) Hauser, F. M.; Mal,
D. J. Am. Chem. Soc. 1984, 106, 1098-1104. (e) Kraus, G. A.; Sujimoto,
H. Tetrahedron Lett. 1978, 19, 2263-2266. (f) Freskos, J. N.; Morrow,
G. W.; Swenton, J. S. J. Org. Chem. 1985, 50, 805-810. (g) Brade, W.;
Vasella, A. Helv. Chim. Acta 1989, 72, 1649-1657. (h) Shair, M. D.;
Yoon, T. Y.; Mosny, K. K.; Chou, T. C.; Danishefsky, S. J. J. Am. Chem.
Soc. 1996, 118, 9509-9525. (i) Swenton, J. S.; Freskos, J. N.; Dalid-
owicz, P.; Kerns, M. L. J. Org. Chem. 1996, 61, 459-464. (j) Matsumoto,
T.; Yamaguchi, H.; Tanabe, M.; Yasui, Y.; Suzuki, K. Tetrahedron Lett.
2000, 41, 8393-8396. (k) Couladouros, E. A.; Strongilos, A. T.;
Papageorgiou, V. P.; Plyta, Z. F. Chem.-Eur. J. 2002, 8, 1795-1083.
(l) Hauser, F. M.; Liao, L.; Sun, Y. Org. Lett. 2002, 4, 2241-2243. (m)
Hauser, F. M.; Dorsch, W. A. Org. Lett. 2003, 5, 3753-3754.
(13) Na´jera, C.; Yus, M. Tetrahedron 1999, 55, 10547-10658.
(14) Giovannini, R.; Petrini, M. Synlett 1995, 973-974.
(15) Frutos, D. O.; Atienza, C.; Echavarren, A. M. Eur. J. Org. Chem.
2001, 163-171.
(16) (a) Matsumoto, T.; Yamaguchi, H.; Tanabe, M.; Yasui, Y.;
Suzuki, K. Tetrahedron Lett. 2000, 41, 8393-8395. (b) Tatuta, K.;
Ozeki, H.; Yamaguchi, M.; Tanaka, M.; Okui, T. Tetrahedron Lett.
1990, 31, 5495-5498.
J. Org. Chem, Vol. 70, No. 22, 2005 9019